It’s Time to Acknowledge Access as a Prescribing Barrier
A recent survey found that on average doctors would prescribe a different therapy for 33% of their patients if medication access was not a factor.
OptimizeRx to Participate in Upcoming May Conferences
OPRX management will participate in the RBC Healthcare Conference in NYC and the B. Riley Annual Institutional Conference in CA.
OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition
Revenue Up 22% to $13.7 million on increased average revenue per top 20 pharmaceutical manufacturer client
OptimizeRx Releases First Environmental, Social and Governance (ESG) Report
The report details OptimizeRx’s initiatives, performance, and strategies to disclose its most significant economic, social, and environmental impacts.
OptimizeRx Sets First Quarter Fiscal 2022 Conference Call for Wednesday, May 4 at 4:30 p.m. ET
OptimizeRx leadership will discuss its results for the first quarter, ended March 31, 2022
Surveyed Physicians Say Access Challenges Impact Their Care Plans for up to 33% of Patients
Physicians report that medication access impacts initial therapy choice for some patients and may require changes to preferred treatment plan.
